A new study confirms that popular cholesterol-lowering statins reduce the risk of major cardiovascular events, including heart attacks and strokes, by 30% in older adults.
The findings, presented at the ESC 2026 conference, reinforce the efficacy of statins despite the emergence of newer, more expensive PCSK9 inhibitor treatments.
Medical professionals are now updating guidelines to ensure wider access to these medications for high-risk elderly populations to improve disability-free survival.